{"id":"glicazide","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-27T23:47:16.325Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03433248","phase":"PHASE4","title":"Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES","status":"UNKNOWN","sponsor":"M.H.H. Kramer","startDate":"2017-11-09","conditions":"Type2 Diabetes","enrollment":66},{"nctId":"NCT04298684","phase":"PHASE4","title":"Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de la Guadeloupe","startDate":"2021-01-01","conditions":"Diabetes Mellitus, Type 2, Thyroid Nodule (Benign)","enrollment":90},{"nctId":"NCT00568984","phase":"PHASE4","title":"Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-11-21","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":324}],"_emaApprovals":[],"_faersSignals":[{"count":9,"reaction":"ACUTE KIDNEY INJURY"},{"count":6,"reaction":"DECREASED APPETITE"},{"count":6,"reaction":"FOURNIER^S GANGRENE"},{"count":6,"reaction":"MALAISE"},{"count":6,"reaction":"METABOLIC ACIDOSIS"},{"count":6,"reaction":"NAUSEA"},{"count":5,"reaction":"BLOOD GLUCOSE INCREASED"},{"count":5,"reaction":"CONFUSIONAL STATE"},{"count":5,"reaction":"DRUG INEFFECTIVE"},{"count":5,"reaction":"DYSPNOEA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":14,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"glicazide","genericName":"glicazide","companyName":"Novo Nordisk A/S","companyId":"novo-nordisk-a-s","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}